trending Market Intelligence /marketintelligence/en/news-insights/trending/8fgjaK1ChgOajqc2rkSu0Q2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Bioasis closes C$1.3M private placement of units


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Bioasis closes C$1.3M private placement of units

Bioasis Technologies Inc. issued a total of 4,588,978 units at 28 Canadian cents apiece in a previously announced private placement, raising C$1.3 million gross proceeds.

Each unit consisted of a common share and one share purchase warrant, with the warrants exercisable to buy an additional share at 60 Canadian cents apiece within a 48-month period after the offering's closing.

Net proceeds will be used to support ongoing research and development, clinical development, manufacturing and other activities, as well as for working capital and general corporate purposes.

Guilford, Conn.-based Bioasis develops products to diagnose and treat neurological diseases and disorders using its proprietary technology.